{
    "Trade/Device Name(s)": [
        "BD Phoenix\u2122 Automated Microbiology System - Amoxicillin (0.0313-32 \u00b5g/mL)",
        "BD Phoenix\u2122M Automated Microbiology System Amoxicillin (0.0313-32 \u00b5g/mL) - Streptococcus ID/AST or AST"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K051692",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020321",
        "K020323",
        "K020322"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "July 14, 2005",
    "Summary Letter Received Date": "June 23, 2005",
    "Submission Date": "June 21, 2005",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Amoxicillin"
    ],
    "Specimen Type(s)": [
        "Pure culture isolates of Gram-negative aerobic and facultative anaerobic bacteria",
        "Pure culture isolates of Gram-positive bacteria (Staphylococcus, Enterococcus, Streptococcus)",
        "Streptococcus pneumoniae",
        "Streptococcus spp. (\u03b1- and \u03b2-hemolytic strains only)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Broth microdilution",
        "Redox indicator",
        "Automated identification and antimicrobial susceptibility testing"
    ],
    "Methodologies": [
        "Microdilution",
        "Automated antimicrobial susceptibility testing",
        "Quantitative MIC determination"
    ],
    "Submission Type(s)": [
        "System",
        "Panel",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix Automated Microbiology System with Amoxicillin panel for Streptococcus susceptibility testing",
    "Indications for Use Summary": "For in vitro quantitative determination of antimicrobial susceptibility by MIC of Gram-negative aerobic/facultative anaerobic and Gram-positive (Staphylococcus, Enterococcus, Streptococcus) bacteria from pure culture; specifically adds amoxicillin (0.0313-32 \u00b5g/mL) to Streptococcus ID/AST or AST panels",
    "fda_folder": "Microbiology"
}